Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | PLA2G4B | P0C869 | 8/20 | 0.63 |
| ▸ | PPARA | Q07869 | 1/20 | 0.61 |
| ▸ | RARB | P10826 | 3/20 | 0.60 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.59 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL10698835 | 0.93 | TP53 (0.68) | LTB4RTP53TSHRPLA2G4BPPARA | |
| Acetic Acid SCHEMBL10695213 | 0.91 | TP53 (0.69) | LTB4RTP53TSHRPLA2G4BRARB | |
| Acetic Acid SCHEMBL10697082 | 0.91 | TP53 (0.69) | LTB4RTP53TSHRPLA2G4BRARB | |
| SCHEMBL534947 | 0.84 | TP53 (0.73) | TP53TSHRPLA2G4BPPARARARB | |
| SCHEMBL7921632 | 0.84 | TP53 (0.73) | TP53TSHRPLA2G4BPPARARARB | |
| SCHEMBL6648277 | 0.84 | TP53 (0.73) | TP53TSHRPLA2G4BPPARARARB | |
| SCHEMBL15806798 | 0.84 | TP53 (0.73) | TP53TSHRPLA2G4BPPARARARB | |
| SCHEMBL11001285 | 0.84 | TP53 (0.73) | TP53TSHRPLA2G4BPPARARARB | |
| SCHEMBL18774788 | 0.84 | TP53 (0.73) | TP53TSHRPLA2G4BPPARARARB | |
| SCHEMBL534753 | 0.84 | TP53 (0.73) | TP53TSHRPLA2G4BPPARARARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0276064-A1 | Anti-inflammatory agents | ELI LILLY AND COMPANY (US) | 1988-07-27 | — | — | EP | disclosed |